Company profile for Avenue Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Avenue Therapeutics is a New York-based, specialty pharmaceutical company founded in 2015. We are a subsidiary company of Fortress Biotech, Inc., a biopharmaceutical company focused on acquiring, developing and commercializing novel pharmaceutical and biotechnology products.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2 Gansevoort Street 9th Floor New York, NY 10014
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/14/2981611/0/en/Avenue-Therapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Recent-Corporate-Highlights.html

GLOBENEWSWIRE
14 Nov 2024

https://www.globenewswire.com//en/news-release/2024/10/09/2960516/0/en/Avenue-Therapeutics-to-Participate-in-Maxim-Group-s-2024-Healthcare-Virtual-Summit.html

GLOBENEWSWIRE
09 Oct 2024

https://www.globenewswire.com/news-release/2024/09/03/2939710/0/en/Avenue-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
03 Sep 2024

https://www.globenewswire.com/news-release/2024/08/09/2927924/0/en/Avenue-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Recent-Corporate-Highlights.html

GLOBENEWSWIRE
09 Aug 2024

https://www.globenewswire.com/news-release/2024/06/20/2901702/0/en/Avenue-Therapeutics-to-Present-at-the-H-C-Wainwright-5th-Annual-Neuro-Perspectives-Virtual-Conference.html

GLOBENEWSWIRE
20 Jun 2024

https://www.globenewswire.com/news-release/2024/05/16/2883391/0/en/Avenue-Therapeutics-Announces-Last-Patient-Last-Visit-in-Phase-1b-2a-Clinical-Trial-of-AJ201-for-the-Treatment-of-Spinal-and-Bulbar-Muscular-Atrophy-Kennedy-s-Disease.html

GLOBENEWSWIRE
16 May 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty